AAVXF
Price
$6.91
Change
+$1.02 (+17.32%)
Updated
Mar 10 closing price
Capitalization
382.82M
ACHV
Price
$2.40
Change
-$0.16 (-6.27%)
Updated
Apr 3, 02:23 PM (EDT)
Capitalization
88.45M
35 days until earnings call
Ad is loading...

AAVXF vs ACHV

Header iconAAVXF vs ACHV Comparison
Open Charts AAVXF vs ACHVBanner chart's image
Abivax SA
Price$6.91
Change+$1.02 (+17.32%)
Volume$200
Capitalization382.82M
Achieve Life Sciences
Price$2.40
Change-$0.16 (-6.27%)
Volume$100
Capitalization88.45M
AAVXF vs ACHV Comparison Chart
Loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AAVXF vs. ACHV commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAVXF is a Buy and ACHV is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (AAVXF: $6.91 vs. ACHV: $2.55)
Brand notoriety: AAVXF and ACHV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAVXF: 68% vs. ACHV: 79%
Market capitalization -- AAVXF: $382.82M vs. ACHV: $88.45M
AAVXF [@Biotechnology] is valued at $382.82M. ACHV’s [@Biotechnology] market capitalization is $88.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAVXF’s FA Score shows that 0 FA rating(s) are green whileACHV’s FA Score has 0 green FA rating(s).

  • AAVXF’s FA Score: 0 green, 5 red.
  • ACHV’s FA Score: 0 green, 5 red.
According to our system of comparison, both AAVXF and ACHV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 3 TA indicator(s) are bullish.

  • ACHV’s TA Score: 3 bullish, 4 bearish.

Price Growth

AAVXF (@Biotechnology) experienced а 0.00% price change this week, while ACHV (@Biotechnology) price change was -12.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.55%. For the same industry, the average monthly price growth was -9.63%, and the average quarterly price growth was -13.98%.

Reported Earning Dates

ACHV is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-7.55% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAVXF($383M) has a higher market cap than ACHV($88.4M). ACHV YTD gains are higher at: -27.557 vs. AAVXF (-37.466).
AAVXFACHVAAVXF / ACHV
Capitalization383M88.4M433%
EBITDAN/A-37.42M-
Gain YTD-37.466-27.557136%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A34.3M-
Total DebtN/A9.96M-
FUNDAMENTALS RATINGS
AAVXF vs ACHV: Fundamental Ratings
AAVXF
ACHV
OUTLOOK RATING
1..100
4281
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
6390
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHV's Valuation (63) in the Biotechnology industry is in the same range as AAVXF (74) in the null industry. This means that ACHV’s stock grew similarly to AAVXF’s over the last 12 months.

ACHV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AAVXF (100) in the null industry. This means that ACHV’s stock grew similarly to AAVXF’s over the last 12 months.

AAVXF's SMR Rating (99) in the null industry is in the same range as ACHV (100) in the Biotechnology industry. This means that AAVXF’s stock grew similarly to ACHV’s over the last 12 months.

AAVXF's Price Growth Rating (63) in the null industry is in the same range as ACHV (90) in the Biotechnology industry. This means that AAVXF’s stock grew similarly to ACHV’s over the last 12 months.

AAVXF's P/E Growth Rating (100) in the null industry is in the same range as ACHV (100) in the Biotechnology industry. This means that AAVXF’s stock grew similarly to ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHV
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IOBT1.070.07
+7.41%
IO Biotech
BRBR76.881.74
+2.32%
BellRing Brands
LOB27.280.44
+1.64%
Live Oak Bancshares
COST965.0810.68
+1.12%
Costco Wholesale Corp
PGC29.250.19
+0.65%
Peapack-Gladstone Financial Corp

AAVXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AAVXF has been loosely correlated with BPMUF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AAVXF jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAVXF
1D Price
Change %
AAVXF100%
N/A
BPMUF - AAVXF
47%
Loosely correlated
N/A
MLEC - AAVXF
38%
Loosely correlated
+8.28%
CNSP - AAVXF
34%
Loosely correlated
-3.10%
ACHV - AAVXF
28%
Poorly correlated
+1.59%
RENB - AAVXF
26%
Poorly correlated
+4.67%
More

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with AXSM. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then AXSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
+1.59%
AXSM - ACHV
36%
Loosely correlated
-1.72%
PLRX - ACHV
36%
Loosely correlated
+2.92%
PDSB - ACHV
34%
Loosely correlated
+6.94%
ATOS - ACHV
33%
Poorly correlated
+5.62%
ABOS - ACHV
32%
Poorly correlated
+0.47%
More